HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

New Jersey Microbeads Bill Advances With Aggressive Phase-Out Timeline

This article was originally published in The Rose Sheet

Executive Summary

Production and sale of microbead-containing cosmetics would be outlawed at the start of calendar years 2015 and 2018, respectively, under New Jersey’s bill, which passed the state’s general assembly at the end of September. The proposed timeline is considerably more aggressive than that in Illinois’ ban, which became law in June with industry’s support.

You may also be interested in...



In Brief: House Microbead Bill; “Wrinkle-Prone” U.S. States; Pantene’s “Not Sorry”

A House bill introduced June 18 would ban the sale of personal-care products containing synthetic plastic microbeads by 2018; J&J’s RoC brand releases study identifying the U.S.’s most “wrinkle-prone” cities; Pantene urges women to reserve their apologies. More news in brief.

US Senate Wants PFAS Banned From Cosmetics. Should FDA Have A Say?

Per- and polyfluoroalkyl substances are unpopular, sure. But there are thousands of PFAS with dissimilar safety profiles that merit US FDA review ahead of a blanket ban in cosmetic products, industry says.

US FDA Inaction On Formaldehyde In Hair-Smoothing Products ‘Unconscionable,’ Petitioners Say

The Environmental Working Group and Women’s Voices for the Earth try again with a petition to the US Food and Drug Administration seeking a ban on use of formaldehyde and equivalents in heated hair-straightening products. This time they are joined by 75 concerned salon workers.

Related Companies

UsernamePublicRestriction

Register

RS019256

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel